Huang H, Shah K, Bradbury N A, Li C, White C
Department of Physiology & Biophysics, Rosalind Franklin University of Medicine & Science, North Chicago, IL, USA.
1] Molecular Targets Program, James Graham Brown Cancer Center, Louisville, KY, USA [2] Department of Medicine, Pharmacology and Toxicology, University of Louisville, Louisville, KY, USA.
Cell Death Dis. 2014 Oct 23;5(10):e1482. doi: 10.1038/cddis.2014.419.
Mcl-1 is an antiapoptotic member of the Bcl-2 family frequently upregulated in non-small cell lung carcinoma (NSCLC). We now report the physiological significance of an interaction between Mcl-1 and the mitochondrial outer membrane-localized voltage-dependent anion channel (VDAC) in NSCLC cell lines. Mcl-1 bound with high affinity to VDAC1 and 3 isoforms but only very weakly to VDAC2 and binding was disrupted by peptides based on the VDAC1 sequence. In A549 cells, reducing Mcl-1 expression levels or application of VDAC-based peptides limited Ca(2+) uptake into the mitochondrial matrix, the consequence of which was to inhibit reactive oxygen species (ROS) generation. In A549, H1299 and H460 cells, both Mcl-1 knockdown and VDAC-based peptides attenuated cell migration without affecting cell proliferation. Migration was rescued in Mcl-1 knockdown cells by experimentally restoring ROS levels, consistent with a model in which ROS production drives increased migration. These data suggest that an interaction between Mcl-1 and VDAC promotes lung cancer cell migration by a mechanism that involves Ca(2+)-dependent ROS production.
Biochim Biophys Acta. 2012-6
Adv Cancer Res. 2018-3-2
Biochim Biophys Acta. 2010
Front Cell Dev Biol. 2025-6-30
Acta Biochim Biophys Sin (Shanghai). 2024-7-8
Biomed Res Int. 2013-7-31
Cell Death Differ. 2013-7-5
Cold Spring Harb Perspect Biol. 2013-2-1
Nat Methods. 2012-7